PharmaShots | Incisive News in 3 Shots

Subscribe Now

ODAC

Celltrion and Teva Announces Approval Recommendations for CT-P10's (rituximab- biosimilar) BLA from the US FDA ODAC

Celltrion and Teva Announces Approval Recommendations for CT-P10's (rituximab- biosimilar) BLA from the US FDA ODAC

October 11, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us